Sedation and shivering management after cardiac arrest.
Eur Heart J Acute Cardiovasc Care
; 12(8): 518-524, 2023 Aug 24.
Article
em En
| MEDLINE
| ID: mdl-37479475
ABSTRACT
Management of sedation and shivering during targeted temperature management (TTM) after cardiac arrest is limited by a dearth of high-quality evidence to guide clinicians. Data from general intensive care unit (ICU) populations can likely be extrapolated to post-cardiac arrest patients, but clinicians should be mindful of key differences that exist between these populations. Most importantly, the goals of sedation after cardiac arrest are distinct from other ICU patients and may also involve suppression of shivering during TTM. Drug metabolism and clearance are altered considerably during TTM when a low goal temperature is used, which can delay accurate neuroprognostication. When neuromuscular blockade is used to prevent shivering, sedation should be deep enough to prevent awareness and providers should be aware that this can mask clinical manifestations of seizures. However, excessively deep or prolonged sedation is associated with complications including delirium, infections, increased duration of ventilatory support, prolonged ICU length of stay, and delays in neuroprognostication. In this manuscript, we review sedation and shivering management best practices in the post-cardiac arrest patient population.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Parada Cardíaca
/
Hipotermia Induzida
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article